James Garvey

About

James Garvey joined SVLS in May 1995 and served as CEO & Managing Partner of SVLS through 2009. James brings a successful healthcare investment track record, preceded by 18 years of operating management experience. James has served on the boards of private and public companies in the US and Europe including Achillion Pharmaceuticals, Allscripts Pharmaceuticals, Arris Pharmaceuticals, LaserVision Centers, Orthovita, Shire Pharmaceuticals and Sunrise Assisted Living. More recent private company investments include Acufocus, Cardiofocus, Halscion, Ocular Therapeutics and recently exited LenSx and CHF Solutions.

Investment Focus

Location

Boston, US